Yeah, doc, sometimes seems that way to me too! I suggest the questioners go off to the DNDN board for a month or two and worry at their changes with IMPACT, while Repros gets on and runs its PIII trials and gives us some results. Not one comment yet on DNDN ihub board on what should be a field day for biostat / trial design aficionados? Weird.
Market Data 
Markets 
AI
